Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 24.7318.950.37-16.3434.26

What is the latest EBIT Growth ratio of EMCURE PHARMACEUTICALS ?

The latest EBIT Growth ratio of EMCURE PHARMACEUTICALS is 24.73 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202624.73
Mar202518.95
Mar20240.37
Mar2023-16.34
Mar202234.26

How is EBIT Growth of EMCURE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2026 24.73
30.50
Mar2025 18.95
5,021.62
Mar2024 0.37
Positive
Mar2023 -16.34
Negative
Mar2022 34.26 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹37,498.9 Cr 2.6% -1.6% 44.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

2.6%

-1.6%

44.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses